Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.

Vaccine
A D BarrettP D Minor

Abstract

Two panels of envelope glycoprotein reactive monoclonal antibodies (mAbs) were prepared against yellow fever (YF) 17D vaccine viruses. Five mAbs were prepared against the World Health Organization 17D-204 avian leukosis virus-free secondary seed virus and eight mAbs against 17DD vaccine manufactured in Brazil. The majority of these mAbs were type-specific and displayed differing reactions in neutralization tests. One, B14, would only neutralize YF vaccine virus grown in invertebrate cells. Others would differentiate 17D-204 and 17DD vaccines, from different manufacturers, in neutralization tests when the viruses were grown in vertebrate cells. The data indicate that heterogeneity exists between the epitopes that elicit neutralizing antibody on YF vaccine from different manufacturers.

Citations

Jul 14, 2001·Virus Research·M F SaeedA D Barrett
Jun 1, 1992·Biologicals : Journal of the International Association of Biological Standardization·T N LedgerA D Barrett
Jul 21, 2001·Lancet·P F VasconcelosUNKNOWN Brazilian Yellow Fever Vaccine Evaluation Group
Dec 3, 2016·PLoS Neglected Tropical Diseases·Matthew T AliotaDavid H O'Connor
Nov 5, 2019·Viral Immunology·Emily H Davis, Alan D T Barrett
Aug 24, 2018·Genes·Raphaëlle KlittingXavier de Lamballerie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.